Sarcopenia: assessment of disease burden and strategies to improve outcomes

Ilaria Liguori,1 Gennaro Russo,1 Luisa Aran,1 Giulia Bulli,1 Francesco Curcio,1 David Della-Morte,2,3 Gaetano Gargiulo,4 Gianluca Testa,1,5 Francesco Cacciatore,1,6 Domenico Bonaduce,1 Pasquale Abete1 1Department of Translational Medical Sciences, University of Naples “Federico II&rdq...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liguori I, Russo G, Aran L, Bulli G, Curcio F, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/f372dd65cece4471bba91ba442d80e9d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f372dd65cece4471bba91ba442d80e9d
record_format dspace
spelling oai:doaj.org-article:f372dd65cece4471bba91ba442d80e9d2021-12-02T04:57:46ZSarcopenia: assessment of disease burden and strategies to improve outcomes1178-1998https://doaj.org/article/f372dd65cece4471bba91ba442d80e9d2018-05-01T00:00:00Zhttps://www.dovepress.com/sarcopenia-assessment-of-disease-burden-and-strategies-to-improve-outc-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Ilaria Liguori,1 Gennaro Russo,1 Luisa Aran,1 Giulia Bulli,1 Francesco Curcio,1 David Della-Morte,2,3 Gaetano Gargiulo,4 Gianluca Testa,1,5 Francesco Cacciatore,1,6 Domenico Bonaduce,1 Pasquale Abete1 1Department of Translational Medical Sciences, University of Naples “Federico II”, Naples, Italy; 2Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 3Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Rome, Italy; 4Division of Internal Medicine, AOU San Giovanni di Dio e Ruggi di Aragona, Salerno, Italy; 5Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy; 6Azienda Ospedaliera dei Colli, Monaldi Hospital, Heart Transplantation Unit, Naples, Italy Abstract: Life expectancy is increasing worldwide, with a resultant increase in the elderly population. Aging is characterized by the progressive loss of skeletal muscle mass and strength – a phenomenon called sarcopenia. Sarcopenia has a complex multifactorial pathogenesis, which involves not only age-related changes in neuromuscular function, muscle protein turnover, and hormone levels and sensitivity, but also a chronic pro-inflammatory state, oxidative stress, and behavioral factors – in particular, nutritional status and degree of physical activity. According to the operational definition by the European Working Group on Sarcopenia in Older People (EWGSOP), the diagnosis of sarcopenia requires the presence of both low muscle mass and low muscle function, which can be defined by low muscle strength or low physical performance. Moreover, biomarkers of sarcopenia have been identified for its early detection and for a detailed identification of the main pathophysiological mechanisms involved in its development. Because sarcopenia is associated with important adverse health outcomes, such as frailty, hospitalization, and mortality, several therapeutic strategies have been identified that involve exercise training, nutritional supplementation, hormonal therapies, and novel strategies and are still under investigation. At the present time, only physical exercise has showed a positive effect in managing and preventing sarcopenia and its adverse health outcomes. Thus, further well-designed and well-conducted studies on sarcopenia are needed. Keywords: sarcopenia, elderly, assessment, therapyLiguori IRusso GAran LBulli GCurcio FDella-Morte DGargiulo GTesta GCacciatore FBonaduce DAbete PDove Medical PressarticlesarcopeniaelderlyassessmenttherapyGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 13, Pp 913-927 (2018)
institution DOAJ
collection DOAJ
language EN
topic sarcopenia
elderly
assessment
therapy
Geriatrics
RC952-954.6
spellingShingle sarcopenia
elderly
assessment
therapy
Geriatrics
RC952-954.6
Liguori I
Russo G
Aran L
Bulli G
Curcio F
Della-Morte D
Gargiulo G
Testa G
Cacciatore F
Bonaduce D
Abete P
Sarcopenia: assessment of disease burden and strategies to improve outcomes
description Ilaria Liguori,1 Gennaro Russo,1 Luisa Aran,1 Giulia Bulli,1 Francesco Curcio,1 David Della-Morte,2,3 Gaetano Gargiulo,4 Gianluca Testa,1,5 Francesco Cacciatore,1,6 Domenico Bonaduce,1 Pasquale Abete1 1Department of Translational Medical Sciences, University of Naples “Federico II”, Naples, Italy; 2Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 3Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Rome, Italy; 4Division of Internal Medicine, AOU San Giovanni di Dio e Ruggi di Aragona, Salerno, Italy; 5Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy; 6Azienda Ospedaliera dei Colli, Monaldi Hospital, Heart Transplantation Unit, Naples, Italy Abstract: Life expectancy is increasing worldwide, with a resultant increase in the elderly population. Aging is characterized by the progressive loss of skeletal muscle mass and strength – a phenomenon called sarcopenia. Sarcopenia has a complex multifactorial pathogenesis, which involves not only age-related changes in neuromuscular function, muscle protein turnover, and hormone levels and sensitivity, but also a chronic pro-inflammatory state, oxidative stress, and behavioral factors – in particular, nutritional status and degree of physical activity. According to the operational definition by the European Working Group on Sarcopenia in Older People (EWGSOP), the diagnosis of sarcopenia requires the presence of both low muscle mass and low muscle function, which can be defined by low muscle strength or low physical performance. Moreover, biomarkers of sarcopenia have been identified for its early detection and for a detailed identification of the main pathophysiological mechanisms involved in its development. Because sarcopenia is associated with important adverse health outcomes, such as frailty, hospitalization, and mortality, several therapeutic strategies have been identified that involve exercise training, nutritional supplementation, hormonal therapies, and novel strategies and are still under investigation. At the present time, only physical exercise has showed a positive effect in managing and preventing sarcopenia and its adverse health outcomes. Thus, further well-designed and well-conducted studies on sarcopenia are needed. Keywords: sarcopenia, elderly, assessment, therapy
format article
author Liguori I
Russo G
Aran L
Bulli G
Curcio F
Della-Morte D
Gargiulo G
Testa G
Cacciatore F
Bonaduce D
Abete P
author_facet Liguori I
Russo G
Aran L
Bulli G
Curcio F
Della-Morte D
Gargiulo G
Testa G
Cacciatore F
Bonaduce D
Abete P
author_sort Liguori I
title Sarcopenia: assessment of disease burden and strategies to improve outcomes
title_short Sarcopenia: assessment of disease burden and strategies to improve outcomes
title_full Sarcopenia: assessment of disease burden and strategies to improve outcomes
title_fullStr Sarcopenia: assessment of disease burden and strategies to improve outcomes
title_full_unstemmed Sarcopenia: assessment of disease burden and strategies to improve outcomes
title_sort sarcopenia: assessment of disease burden and strategies to improve outcomes
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/f372dd65cece4471bba91ba442d80e9d
work_keys_str_mv AT liguorii sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT russog sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT aranl sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT bullig sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT curciof sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT dellamorted sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT gargiulog sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT testag sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT cacciatoref sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT bonaduced sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
AT abetep sarcopeniaassessmentofdiseaseburdenandstrategiestoimproveoutcomes
_version_ 1718400985327468544